Larry Hsu is Director at IMPAX LABORATORIES INC (IPXL). They have made 11 open-market trades across 2 companies since 2009, most recently 2015-05-12.
CIK 0001245199
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $1.2M since 2009, against 4 sales. Across 6 scored buys the stock is up 0.8% at ninety days, and 0.5 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -14.0% | +0.8% | +0.8% |
| Alpha | -8.2% | +0.5% | +0.5% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IPXL | SELL | 2014-06-05 | 2014-06-09 | $28.39 | $2.8M | -14.0% | +0.8% | +0.8% |
| IPXL | SELL | 2014-05-22 | 2014-05-23 | $27.22 | $1.4M | -14.0% | +0.8% | +0.8% |
| IPXL | SELL | 2014-05-21 | 2014-05-22 | $26.53 | $101K | -14.0% | +0.8% | +0.8% |
| IPXL | SELL | 2014-05-06 | 2014-05-08 | $26.28 | $5.8M | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2013-03-12 | 2013-03-14 | $16.88 | $118K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2011-08-16 | 2011-08-16 | $19.00 | $190K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2010-08-12 | 2010-08-12 | $15.40 | $77K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2010-08-11 | 2010-08-12 | $16.03 | $160K | -14.0% | +0.8% | +0.8% |
| IPXL.OB | BUY | 2009-01-27 | 2009-01-27 | $5.00 | $250K | N/A | N/A | N/A |
| IPXL | BUY | 2009-01-23 | 2009-01-26 | $3.80 | $49K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2009-01-22 | 2009-01-23 | $3.98 | $347K | -14.0% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.